Results 301 to 310 of about 234,277 (395)
Movement Disorders Clinical Practice, Volume 12, Issue 3, Page 392-396, March 2025.
James Manfield+5 more
wiley +1 more source
Effects of intermittent theta burst stimulation versus repetitive transcranial magnetic stimulation on post-stroke dysphagia in hospitalised patients: study protocol for a prospective, randomised controlled trial. [PDF]
Chen X+7 more
europepmc +1 more source
Abstract Background Alterations in gut microbiota are observed in Parkinson's disease (PD). Previous studies on microbiota‐derived metabolites in PD were small‐scale and post‐diagnosis, raising concerns about reverse causality. Objectives Our goal was to prospectively investigate the association between plasma microbial metabolites and PD risk within a
Yujia Zhao+20 more
wiley +1 more source
Comment on Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442. [PDF]
Trosch R, Parreirinha D, Proeschel S.
europepmc +1 more source
VPS13A disease has become paradigmatic for a new pathophysiological concept in neurodegeneration: disturbed bulk lipid transfer at membrane contact sites. VPS13A is a bridge‐like lipid transfer protein. Loss of VPS13A function leads to deformed red blood cells (RBCs), acanthocytes.
Kevin Peikert+7 more
wiley +1 more source
Abstract Background Pallidal neurostimulation is an effective treatment for severe isolated dystonia, but long‐term data from clinical trials are lacking. Objectives To evaluate long‐term efficacy and safety of pallidal neurostimulation in patients with isolated generalized or segmental dystonia.
Patricia Krause+60 more
wiley +1 more source
Endoscopic and videofluoroscopic evaluations of swallowing for dysphagia: A systematic review. [PDF]
Ferrari de Castro MA+6 more
europepmc +1 more source
Abstract Background Patients with mutations in the monocarboxylate transporter 8 (MCT8, SLC16A2) suffer from X‐linked recessive Allan‐Herndon‐Dudley syndrome (AHDS), which is characterized by developmental delay and a severe movement disorder. Current trials using thyroid hormone derivatives to overcome the transporter defect have failed to achieve ...
Nina‐Maria Wilpert+21 more
wiley +1 more source